Abbott Laboratories - CEDEAR (ABT)
BCBA
Closed
Oct 8, 2026
Day's Range
39,160.0052 wk Range
30,380.00Overview - ABT - Abbott Laboratories - CEDEAR
Key Statistics
Valuation
Enterprise Value
415,470.39T
P/E (Trailing)
‪4.19‬
PEG Ratio
‪-0.08‬
Price / Sales (TTM)
‪734.72‬
Price / Book
‪3.51‬
EV / EBITDA
‪23,324.99‬
Profitability
Profit Margin
‪11.64%‬
Operating Margin
‪14.70%‬
Return on Assets
‪5.32%‬
Return on Equity
‪10.57%‬
Ownership
Shares Outstanding
865.19M
Float
6.87B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.58‬
50-Day Avg
‪42,630.80‬
200-Day Avg
‪39,392.80‬
Dividends
Payout Ratio
‪9.87%‬
Frequency
Quarterly
Market Cap - ABT - Abbott Laboratories - CEDEAR
Peers - ABT - Abbott Laboratories - CEDEAR
Peer Comparison
Compared with companies in Medical Devices listed on BCBA.
Profile Summary - ABT - Abbott Laboratories - CEDEAR
About
Abbott Laboratories - CEDEAR is a Certificado de Depósito Argentino (CEDEAR) representing shares of Abbott Laboratories, a global healthcare company specializing in medical devices, diagnostics, nutritional products, and branded generic medicines. This financial instrument enables Argentine investors to gain exposure…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
